Process Development of Febuxostat Using Palladium- and Copper-Catalyzed C–H Arylation

Nao Yajima,Y. Kato,Masayuki Kurokawa,Kunio Minamizono,Yoshinori Sato,M. Dohi,Hideyoshi Tsuchiya,Mitsuru Teramoto,M. Komiyama,Naoki Tsuchiya
DOI: https://doi.org/10.1021/ACS.OPRD.8B00164
IF: 3.4
2018-09-07
Organic Process Research & Development
Abstract:There is significant interest in the development of process routes for active pharmaceutical ingredients using C–H arylation methodology. An efficient and practical synthetic route for febuxostat (1), which is the first non-purine-type xanthine oxidase inhibitor, was established via palladium- and copper-catalyzed C–H arylation of thiazole with aryl bromide. The catalyst loading was reduced to 0.1 mol % for the intermolecular C–H arylation, and a three-step synthesis produced febuxostat in 89% overall yield with excellent selectivity.
Chemistry
What problem does this paper attempt to address?